Koyfin Home > Directory > Health Care > Akebia Therapeutics > Price / Earnings (ltm)

Akebia Therapeutics Price / Earnings (ltm) Chart (AKBA)

Akebia Therapeutics annual/quarterly Price / Earnings (ltm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin